Skip to content

Amneal Pharmaceuticals, Inc. AMRX Proceeds from disposals of property, plant and equipment

Proceeds from disposals of property, plant and equipment at other companies

Cardinal Health logo
Cardinal HealthCAH
AptarGroup logo
AptarGroupATR

Other financials

Income statement

See full
Revenue$722.5M+3.9%
Gross profit$320.1M+25.1%
Operating income$141.8M+41.3%
Net income$62.3M+411%
EPS (diluted)$0.19+375%

Balance sheet

See full
Cash & equivalents$197.7M+234%
Total debt$2.6B+17.7%
Total equity-$45.4M+65.5%
Total assets$3.5B+5.2%

Cash flow

See full
Operating cash flow-$26.7M-461%
CapEx$8.2M-37.9%
Free cash flow-$34.9M-507%

Valuation

See full
Market cap$5.17B+51.0%
Enterprise value$7.55B+33.4%
P/E42.4×
P/S1.7×+0.5×

Profitability

See full
Gross margin38.7%+2.0pp
Operating margin14.3%+1.6pp
Net margin4%+3.6pp
FCF margin7.9%-1.0pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity127.9×+119×
Current ratio2.5×+1.1×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment?
Amneal Pharmaceuticals, Inc. (AMRX) reported proceeds from disposals of property, plant and equipment of $0 in Q1 2026.
How has Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment changed year-over-year?
Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment decreased by 100.0% year-over-year, from $524K to $0.